Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Comment: The place for dermatology
Neill Hepburn
Last month I had to present the United Lincolnshire Hospitals NHS Trust’s mortality data and action plan at a ‘mortality summit’ with our clinical commissioning group partners and the local area team from NHS England. As a dermatologist, whose specialty is generally regarded as somewhat less than acute, I felt uncomfortable. I recalled the aphorism, ‘skin patients never die, but nor do they get better!’. Of course, our work has changed greatly over the past 20 years; the increasing prevalence of melanoma and the widespread adoption of immunomodulatory treatments ensure we do look after patients in their final months of life and many of our patients do ‘get better’.
Dermatology in practice
2013;
19
(2): 3–3
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
EC approves Biocon’ Yesintek to treat psoriasis
BMS announces long-term data for Sotyktu in plaque psoriasis
EMA committee recommends Krystal’s Vyjuvek for ultra-rare blistering disease
MHRA approves Galderma’s Nemluvio for two skin diseases
Recce shares positive mid-stage results for topical gel in skin infections
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy